Levocarnitine and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported only by a few people who take Levocarnitine.

The study analyzes which people take Levocarnitine and have Hyperventilation. It is created by eHealthMe based on reports of 3,299 people who have side effects while taking Levocarnitine from the FDA, and is updated regularly.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

What is Hyperventilation?

Hyperventilation is found to be associated with 736 drugs and 1,442 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Jun, 20, 2026

3,299 people reported to have side effects when taking Levocarnitine.
Among them, 3 people (0.09%) have Hyperventilation.

Could Levocarnitine cause Hyperventilation?

Among these 3 people:

How long have people been on Levocarnitine when they have Hyperventilation? *

What is the gender of people who have Hyperventilation when taking Levocarnitine? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperventilation when taking Levocarnitine? *

What are other drugs people take besides Levocarnitine? *

Diacomit: 2 people, 66.67%
Zonisade: 1 person, 33.33%
Melatonin: 1 person, 33.33%
Lacosamide: 1 person, 33.33%
Fluoxetine Hydrochloride: 1 person, 33.33%
Daybue: 1 person, 33.33%

What are other side effects people have besides Hyperventilation? *

Hypoaesthesia (reduced sense of touch or sensation): 2 people, 66.67%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 33.33%
Stress And Anxiety: 1 person, 33.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 33.33%
Rashes (redness): 1 person, 33.33%
Diarrhea: 1 person, 33.33%
Constipation: 1 person, 33.33%
Breath Holding: 1 person, 33.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 33.33%

What are the existing conditions these people have? *

Hyperammonaemia: 2 people, 66.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levocarnitine:

Levocarnitine (3,332 reports)

Browse all side effects of Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (736 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,442 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levocarnitine (the active ingredients of Levocarnitine) and Levocarnitine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.